M A P S Travels Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-07-2024
- Paid Up Capital ₹ 0.50 M
as on 18-07-2024
- Company Age 29 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 58.66%
(FY 2023)
- Profit 780.04%
(FY 2023)
- Ebitda 601.08%
(FY 2023)
- Net Worth 22.19%
(FY 2023)
- Total Assets 48.47%
(FY 2023)
About M A P S Travels
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chellappan Selvan and Deivasigamani Palaniswamy serve as directors at the Company.
- CIN/LLPIN
U63040TZ1995PTC006711
- Company No.
006711
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M A P S Travels?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chellappan Selvan  | Director | 22-Nov-2003 | Current |
| Deivasigamani Palaniswamy | Director | 20-Dec-1996 | Current |
Financial Performance and Corporate Structure Insights of M A P S Travels.
M A P S Travels Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.66% increase. The company also saw a substantial improvement in profitability, with a 780.04% increase in profit. The company's net worth Soared by an impressive increase of 22.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M A P S Travels?
In 2023, M A P S Travels had a promoter holding of 94.80% and a public holding of 5.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
LIMITED.webp)
Edg Pharmaceuticals (India) Private LimitedActive 13 years 3 monthsDeivasigamani Palaniswamy is a mutual person
Purani Hospital Supplies Private LimitedActive 24 years 7 monthsDeivasigamani Palaniswamy is a mutual person
Biomed Hitech Industries LimitedActive 32 years 3 monthsChellappan Selvan and Deivasigamani Palaniswamy are mutual person
LIMITED.webp)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at M A P S Travels?
Unlock and access historical data on people associated with M A P S Travels, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M A P S Travels, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M A P S Travels's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
